Journal article
Fatigue and endocrine symptoms among women with early breast cancer randomized to endocrine versus chemoendocrine therapy: Results from the TAILORx patient‐reported outcomes substudy
Abstract
BACKGROUND: TAILORx (Trial Assigning Individualized Options for Treatment) prospectively assessed fatigue and endocrine symptoms among women with early-stage hormone receptor-positive breast cancer and a midrange risk of recurrence who were randomized to endocrine therapy (E) or chemotherapy followed by endocrine therapy (CT+E).
METHODS: Participants completed the Functional Assessment of Chronic Illness Therapy-Fatigue, the Patient-Reported …
Authors
Garcia SF; Gray RJ; Sparano JA; Tevaarwerk AJ; Carlos RC; Yanez B; Gareen IF; Whelan TJ; Sledge GW; Cella D
Journal
Cancer, Vol. 128, No. 3, pp. 536–546
Publisher
Wiley
Publication Date
February 2022
DOI
10.1002/cncr.33939
ISSN
1097-0142